Intrexon Corporation is a biotechnology company focused on collaborating with companies in Health, Food, Energy, and the Environment to create biologically based products that improve the quality of life and health of the planet. Through the company’s proprietary UltraVector® platform, Intrexon provides its partners with commercial-scale design and development of complex biological systems. The UltraVector® platform enables unprecedented control over the quality, function, and performance of living cells for a wide variety of applications. Intrexon calls it Better DNA™ and invites you to discover more at www.dna.com.
In June 2013, Intrexon leadership filed paperwork with the SEC to launch an IPO.
Sign-up for daily news updates from Technical.ly